Jonathan Salmond
Papers
2
Total Citations
20
H-Index
2
About
Jonathan Salmond is a clinical researcher focused on improving surgical outcomes for men with localized prostate cancer, with a particular emphasis on preserving quality of life after robotic-assisted radical prostatectomy (RARP). His major contribution centers on the NeuroSAFE PROOF trial, a landmark single-blinded, multi-centre, randomized controlled trial designed to evaluate the NeuroSAFE technique—a method that uses intraoperative frozen section analysis of the neurovascular bundles to guide nerve-sparing during RARP. By comparing this approach to standard RARP, Salmond’s work aims to reduce the common and debilitating side effects of postoperative erectile dysfunction and urinary incontinence, which significantly impact patients’ quality of life. The study protocol, published in 2022, has already garnered over 20 citations, reflecting its importance in the field of urologic oncology. Salmond’s research is notable for its rigorous IDEAL stage 3 design, which sets a high standard for evidence-based surgical innovation. His efforts are helping to refine surgical techniques that balance oncologic control with functional preservation, offering hope for better long-term outcomes for prostate cancer patients.
Research Focus
Key Achievements
Top Papers
- 1
- 2